Trial intelligence / Profile preview

Role of antibiotics in conjunction with oral bone augmentation procedures (BAS20)

2020-004564-26Phase 2Active

Sponsor
Karolinska Institutet
Start
Jul 2021
Modality
Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2 trial of phenoxymethylpenicillin in surgical site infection (SSI) (2 arms), sponsored by Karolinska Institutet. Primary endpoints: Occurrence of postoperative infections, Impact on normal oral microflora and 1 more. Started Jul 2021; status: active.

02

Drugs

phenoxymethylpenicillin
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on 2020-004564-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-004564-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call